Solid Biosciences (SLDB) Other financing activities (2017 - 2026)
Solid Biosciences' (SLDB) quarterly Other financing activities came in at $12.9 million in Q1 2026, up 4406.99% quarter-over-quarter from $286000.0 in Q2 2024.
Solid Biosciences (SLDB) Other financing activities (2017 - 2026) Analysis & Trends
Solid Biosciences has disclosed Other financing activities across 5 years of filings, most recently posting $12.9 million for Q1 2026.
- Other financing activities for Q1 2026 came in at $12.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $12.9 million (up 4406.99% YoY), and the FY2024 annual result was $5.1 million, changed N/A from the prior year.
- Other financing activities came in at $12.9 million for Q1 2026 at Solid Biosciences, up from $286000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $12.9 million in Q1 2026 to a low of $286000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Solid Biosciences | 789.54 Mn | 408.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.89 Mn |
| Mar 31, 2026 | 12.89 Mn |
| Jun 30, 2024 | 286,000.00 |
| Jun 30, 2024 | 286,000.00 |
| Mar 31, 2024 | 4.83 Mn |
| Mar 31, 2024 | 4.83 Mn |
| Dec 31, 2019 | 287,000.00 |
| Dec 31, 2019 | 287,000.00 |
| Jun 30, 2018 | 193,000.00 |
| Jun 30, 2018 | 193,000.00 |
| Mar 31, 2018 | 1.98 Mn |
| Mar 31, 2018 | 1.98 Mn |
| Dec 31, 2017 | 1.25 Mn |
| Dec 31, 2017 | 1.25 Mn |
| Sep 30, 2017 | 943,000.00 |
| Sep 30, 2017 | 943,000.00 |
| Jun 30, 2017 | 58,000.00 |
| Jun 30, 2017 | 58,000.00 |
| Mar 31, 2017 | 178,000.00 |
| Mar 31, 2017 | 178,000.00 |